Menü
This security has been delisted
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

New Strong Sell Stocks for July 24th


Here are three stocks added to the Zacks Rank #5 (Strong Sell) List today:

Compass COMP provides an end-to-end platform for residential real estate agents to deliver service to seller and buyer clients. The Zacks Consensus Estimate for its current year earnings has been revised almost 20% downward over the last 60 days.

Elekta EKTAY is a human care company engaged in developing and selling clinical solutions for the treatment of cancer and neurological diseases. The Zacks Consensus Estimate for its current year earnings has been revised 19.1% downward over the last 60 days.

Bausch + Lomb BLCO is an eye health company with product portfolio which includes Biotrue and renu multi-purpose solutions, Biotrue ONEday daily disposable contact lenses, LUMIFY redness reliever eye drops, PreserVision AREDS 2 formula eye vitamin and mineral supplements and VYZULTA. The Zacks Consensus Estimate for its current year earnings has been revised 6% downward over the last 60 days.

View the entire Zacks Rank #5 List.

7 Best Stocks for the Next 30 Days

Just released: Experts distill 7 elite stocks from the current list of 220 Zacks Rank #1 Strong Buys. They deem these tickers "Most Likely for Early Price Pops."

Since 1988, the full list has beaten the market more than 2X over with an average gain of +23.5% per year. So be sure to give these hand picked 7 your immediate attention. 

See them now >>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report


 
Elekta AB (EKTAY): Free Stock Analysis Report
 
Compass, Inc. (COMP): Free Stock Analysis Report
 
Bausch + Lomb Corporation (BLCO): Free Stock Analysis Report

This article originally published on Zacks Investment Research (zacks.com).

Zacks Investment Research


Source Zacks-com

Like: 0
Teilen
At Zacks, we are dedicated to independent investment research, helping investors succeed through tools like our Zacks Rank stock-rating system, which has averaged +23.89% annual returns since 1988. Founded on the discovery that earnings estimate revisions drive stock prices, we offer purely mathematical, unbiased ratings, along with additional innovations like the Price Response Indicator, Earnings ESP, and specialized rankings for mutual funds and ETFs.
...
Rechtlicher Hinweis

Kommentare